Steven L. Hoerter
2012 - Clovis Oncology
In 2012, Steven L. Hoerter earned a total compensation of $1.4M as EVP and Chief Commercial Officer at Clovis Oncology, a 63% increase compared to previous year.
Compensation breakdown
| Bonus | $138,200 |
|---|---|
| Option Awards | $941,322 |
| Salary | $314,167 |
| Other | $14,434 |
| Total | $1,408,123 |
Hoerter received $941.3K in option awards, accounting for 67% of the total pay in 2012.
Hoerter also received $138.2K in bonus, $314.2K in salary and $14.4K in other compensation.
Rankings
In 2012, Steven L. Hoerter's compensation ranked 4,807th out of 11,487 executives tracked by ExecPay. In other words, Hoerter earned more than 58.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,807 out of 11,487 | 58th |
Division Manufacturing | 1,679 out of 4,253 | 61st |
Major group Chemicals And Allied Products | 389 out of 1,198 | 68th |
Industry group Drugs | 246 out of 920 | 73rd |
Industry Pharmaceutical Preparations | 192 out of 700 | 73rd |
Source: SEC filing on April 30, 2015.
Hoerter's colleagues
We found four more compensation records of executives who worked with Steven L. Hoerter at Clovis Oncology in 2012.